Together with Consulting Editor, Dr. Charles Lightdale, Dr. Parkman has created as state-of-the-art issue devoted to the modern technology and approaches for evaluation and treatment of GI motility. He has provided coverage for the esophagus, colon, small intestine, and gut. Leaders in the field have contributed the detailed clinical review articles on the following topics: Enhancing High Resolution Esophageal Manometry: Use of Impedance, multiple rapid swallows, Position change, Solid food boluses, and other techniques; EndoFLIP in the esophagus: Assessing sphincter function, wall stiffness, motility to guide treatments; Evaluation and Treatment of patients with persistent reflux symptoms despite PPI treatment; Esophageal Evaluation for Patients undergoing Lung Transplant Evaluation: What should we do for evaluation and management; Tailoring Endoscopic and Surgical Treatments for GERD; Endoscopic and Surgical Treatments for Achalasia: Who to treat and how; Enhancing Scintigraphy for evaluation of gastric, small bowel, colonic motility; Targeting treatment for gastroparesis: Use of clinical tests to guide treatments; Endoscopic and Surgical Treatments for Gastroparesis: What to do and Whom to treat; Gastric Biopsies in Gastroparesis: Insights to Gastric Neuromuscular Disorders to Help with treatment; SIBO: How to diagnose and treat (and then treat again); Assessing anorectal function in constipation and fecal incontinence; Treating chronic abdominal pain in patients with Chronic Recurrent Abdominal Pain and IBS; and Refractory Chronic Constipation:How to evaluate and treat. Readers will come away with the technical information they need to improve outcomes in their patients.

Together with Consulting Editor, Dr. Alan Buchman, Dr. Parkman has created as state-of-the-art issue devoted to the modern technology and approaches for evaluation and treatment of GI motility. He has provided coverage for the esophagus, colon, small intestine, and gut. Leaders in the field have contributed the detailed clinical review articles on the following topics: Enhancing High Resolution Esophageal Manometry: Use of Impedance, multiple rapid swallows, Position change, Solid food boluses, and other techniques; EndoFLIP in the esophagus: Assessing sphincter function, wall stiffness, motility to guide treatments; Evaluation and Treatment of patients with persistent reflux symptoms despite PPI treatment; Esophageal Evaluation for Patients undergoing Lung Transplant Evaluation: What should we do for evaluation and management; Tailoring Endoscopic and Surgical Treatments for GERD; Endoscopic and Surgical Treatments for Achalasia: Who to treat and how; Enhancing Scintigraphy for evaluation of gastric, small bowel, colonic motility; Targeting treatment for gastroparesis: Use of clinical tests to guide treatments; Endoscopic and Surgical Treatments for Gastroparesis: What to do and Whom to treat; Gastric Biopsies in Gastroparesis: Insights to Gastric Neuromuscular Disorders to Help with treatment; SIBO: How to diagnose and treat (and then treat again); Assessing anorectal function in constipation and fecal incontinence; Treating chronic abdominal pain in patients with Chronic Recurrent Abdominal Pain and IBS; and Refractory Chronic Constipation: How to evaluate and treat. Gastroenterologists will come away with the technical information they need to improve outcomes in their patients.

In collaboration with Consulting Editor, Dr. Norman Gitlin, Dr. Steven Flamm has put together another great update for the hepatology consult. Articles are submitted by expert author and in the format of the clinical review article, provide timely data for diagnosis and treatment. Specific areas addressed include the following: Management of esophageal and gastric varices; Severe thrombocytopenia in chronic liver disease and new management approaches; Pathology in chronic liver disease; Alpha 1 antitrypsin disease and chronic liver disease in adults; Evaluation of management of Budd-Chiari; HBV reactivation with immunosuppressive therapy; Homeopathic products and hepatotoxicity; New uses of TIPS; Dermatologic manifestations of chronic liver disease; Acute on chronic liver failure; Cholangiocarcinoma; Diagnosis and management of hepatic adenoma and focal nodular hyperplasia; Emerging data about the microbiome in chronic liver disease; and Acute viral hepatitis aside from HAV, HBV, and HCV. Readers will come away with the information they need to improve patient outcomes.

John Libbey Eurotext is continuing to publish the proceedings of these courses in gastroenterology organised in Europe by the world's leading specialists. The July course will cover bacterial gastrointestinal infections, which doctors are increasingly called upon to treat. For example diarrhoea, the best known of these conditions, is no longer specific to the developing world and many bacterial infections are now appearing in western countries. Biological and clinical data are presented here in a synoptic work for young practitioners, edited by EAGE president Professor Galmiche. Latest knowledge about the mechanisms of these infections, their interactions with other systems and their medium- and long-term treatments has enabled specialists to lay the first foundations for future therapies, in particular treatments for and vaccines against diarrhoea.

'A major step in patient education and participation in the management of diverticulitis' - Professor Frank A. Frizelle Diverticular disease (DD) is a digestive disorder caused by enflamed diverticula, or pouches, in the colon. A common cause is constipation due to lack of fibre in the diet. Diverticulitis is very common, with about 60,000 new cases diagnosed each year in the UK and 300,000 in the USA. Symptoms are usually persistent abdominal pain plus disturbed bowel function (constipation or diarrhoea or alternating between the two). Diverticulitis sometimes becomes very severe leading to perforation of the bowel, forming an abscess or rarely peritonitis. This best-selling book looks at the treatment and self-management of DD - while the doctor can help, particularly with antibiotics, much can be done by the individual to minimise the effects of this condition. Topics include: The medical treatment of diverticular disease Probiotics ('good' or 'friendly' live bacteria and yeasts said to be good for digestive health The increase of diverticular disease in the population Effects of diverticular disease

Together with Consulting Editor, Dr. Charles Lightdale, Dr. Doug Rex has put together an issue of Gastrointestinal Endoscopy Clinics that provides state-of-the-art clinical coverage of colorectal screening. Expert authors from all over the world have contributed clinical reviews that will be a staple for all practicing endoscopists. The articles are devoted to the following topics: What is organized screening and what is its value; Screening decisions in the opportunistic setting; The National Colorectal Cancer Round Table: Past performance and current and future goals; Proven strategies for increasing screening adherence; Colorectal cancer in persons under age 50: Seeking causes and solutions; Risk stratification strategies: From logistic regression to artificial intelligence; Cost-effectiveness of current screening tests; Quality in colorectal cancer screening; Screening for the serrated pathway; FIT: The world's colorectal cancer screening test; Fecal DNA testing: What has it accomplished and where is it headed; Is bowel preparation without complete colon clearing a viable concept: Update on flexible sigmoidoscopy, CTC, and capsule colonoscopy; Evidenced based screening strategies for a positive family history; Aspirational ADR and ideal colonoscopy performance: How long can we go between colonoscopies; and How Artificial Intelligence will impact colonoscopy and colorectal cancer screening. Readers will come away with the clinical knowledge they need to improve outcomes in colon cancer screening and prevention.

This book covers state-of-the-art topics covering evidences indicate that the gut microbiota can be harnessed for cancer prevention as well as to modulate the efficacy of chemotherapy and immunotherapy. This book includes: 1) characterization of the dysregulated microbiome in gastrointestinal cancers (Chapters 1-6); 2) the molecular mechanism of action of gut microbiota via microbial metabolites and direct interaction with host cancer or immune cells (Chapters 7-11); 3) key methodologies for studying the role of gut microbiota in cancers (Chapters 12-13); and 4) the potential application of gut microbes for the prevention and treatment of gastrointestinal cancers (Chapters 14-17). The contributors are international experts in molecular and cellular biology, microbiology, metabolomics, bioinformatics and physician scientists to provide in-depth reviews of this subject. This book provides a rich resource of information on this important topic for graduate students, basic researchers and physicians.

This book provides specialist and general nurses with a comprehensive guide to the art and science of stoma care nursing, from the Association of Stoma Care Nurses UK, the only association for SCNs in UK. The chapters follow a schematic outline of knowledge required for nurses caring for patients who are undergoing stoma surgery; from the essence of nursing to the management of patients living with a long term condition. It also presents and discusses the issues surrounding the clinical picture such as prescription and community issues as well as sources of support available for patients. This text serves as an excellent resource for all disciplines of health care staff caring for individuals living with a stoma.

The Certified Bariatric Nurse (CBN) designation was created by the American Society for Metabolic and Bariatric Surgery to fill the rapidly growing need for nurses specialized in the care of patients undergoing weight loss surgery. This book approaches this subject area to assist nurses interested in passing the CBN exam. It can also be used as a general resource for those interested in a comprehensive but concise review of the rapidly growing field of Bariatric Surgery. This would include medical students, residents, dietitians, and other allied health professionals. Dr. Marc Neff is a recognized expert in the field of Bariatric Surgery. In his current position, his hospital is fortunate to have several CBNs caring for the Bariatric patients. With his guidance, along with several nurses who successfully completed the CBN designation, the authors have created a concise, "quick hit" review of the material required to successfully pass the exam. The format is short chapters followed by 5-10 review questions with in-depth explanations. Where appropriate, graphics are provided to highlight the essential anatomy and surgical procedures. Questions are in multiple choice format to simulate the actual CBN exam.

This book provides a state-of-the-art description of the clinical evaluation, diagnosis, management, and treatment of achalasia, gastroesophageal reflux disease, paraesophageal hernia, and morbid obesity. The prevalence of such diseases is increasing worldwide due to higher awareness and improved diagnosis rate. The text is divided in three different parts, each covering detailed surgical techniques of the main foregut operations: achalasia, gastroesophageal reflux disease (GERD), and obesity. Written by experts in the field, chapters focus on the preoperative work-up, indications, and technical aspects of each operation. Foregut Surgery proves to be an irreplaceable resource for surgeons, gastroenterologists, medical students, and surgical residents that care for patients with reflux, achalasia, and morbid obesity.

In collaboration with Consulting Editor, Dr. Norman Gitlin, Dr. Pierre Gholam has put together topics that provide a current clinical update on the treatment and management of patients with drug-induced liver injury (DILI). Expert authors have contributed clinical review articles on the following topics: Epidemiology, Predisposing Factors and Outcomes; Genetic Predisposition to DILI; Causality Assessment Frequent Offenders and Patterns of Injury; Quantitative Systems Toxicology Approaches to Understand and Predict DILI; Liver Histology: Diagnostic and Prognostic Features; Acute Liver Failure Secondary to DILI; DILI in Persons with Pre-existing Chronic Liver Disease; DILI in the Setting of Statin Use; DILI in the Setting of Analgesic Use; DILI Secondary to Herbals and Dietary Supplements; and DILI Reporting and Resources for the Clinician. Readers will come away with the information they need to improve outcomes in patients with DILI.

Together with Consulting Editor Dr. Charles Lightdale, Dr. Qiang Cai has put together a comprehensive issue devoted to gastroparesis. Expert authors have contributed clinical review articles on the following topics: Epidemiology and Pathophysiology of Gastroparesis; Non-Diabetic Gastroparesis; Clinical Manifestations and Natural History of Patients with Gastroparesis; Evaluation of Patients with Suspected Gastroparesis; Symptomatic Management of Gastroparesis; Gastric Electrical Stimulator for treatment of Gastroparesis; Surgical Treatment for Gastroparesis; Botulinum Toxin Injection for Treatment of Gastroparesis; Stent Placement for Treatment for Gastroparesis; Technical Aspects of Per Oral Endoscopic Pyloromyotomy; Gastric Emptying Scintigraphy for Evaluation of Patients with Gastroparesis before Per Oral Endoscopic Myotomy; Outcomes of Per Oral Endoscopic Pyrolomyotomy in France; Outcomes of Per Oral Endoscopic Pyloromyotomy in China; Outcomes of Per Oral Endoscopic Pyloromyotomy in the United States.. Readers will come away with the information they need to improve endoscopic techniques and improve patient outcomes.

Covering all aspects of gastrointestinal pathology, this award-winning volume in the Diagnostic Pathology series is an excellent point-of-care resource for pathologists at all levels of experience and training-both as a quick reference and as an efficient review to improve knowledge and skills. This updated third edition is an easy-to-use, one-stop reference for the entire GI system, offering a templated, highly formatted design; concise, bulleted text; and superior color images throughout, enabling you to arrive at the correct diagnosis and prepare actionable, useful reports. Provides comprehensive coverage with the necessary tools to make a comprehensive diagnostic workup Incorporates significant changes in the AJCC cancer staging of gastrointestinal tumors Provides details on PD-L1 (immune checkpoint inhibitor) therapy, new types of colitis, and molecular biology of GI tract tumors as it relates to precision medicine and targeted therapy Discusses timely topics such as GAPP, a newly described form of gastric polyposis that leads to cancer; the increasing complexity of large B-cell lymphomas and which immunostains and molecular tests to order for proper classification and therapy; Immune Modulator therapy effect, which can closely mimic IBD; and newly described polyposis syndromes, such as mixed and serrated polyposis Features more than 2,500 annotated images throughout, including gross pathology, a wide range of stains, and detailed medical illustrations, depicting virtually any GI specimen you're likely to see 2015 BMA Medical Book Awards 1st Prize Award Winner in Pathology Category (previous edition) Enhanced eBook version included with purchase, which allows you to access all of the text, figures, and references from the book on a variety of devices

A Comprehensive Overview of Irritable Bowel Syndrome: Clinical and Basic Science Aspects presents up-to-date knowledge in the field and provides a comprehensive summary of this area of study, including an overview on IBS, starting from its pathogenesis, including genetic, microbial and physiological background, through symptom recognition, diagnosis and IBS treatment, both non-pharmacological and pharmacological.

This book includes studies aimed at determining design interventions in which the composition of microbiota may be modulated to achieve a specific microbial profile beneficial to overall host behavior. In addition, this compilation summarises and critically discusses recent literature on the evaluation of changes in the microbiota associated with liver diseases, aiming to evaluate which alterations could be involved in the initiation and progression of liver disease. The authors emphasize the importance of promoting a balanced microbiome to maintain or improve oral health effectively. In order to fully understand the progression of oral diseases, it is essential to evaluate the microbiome together with genetic, immunological and environmental factors.

Aus den Fachgebieten Gastroenterologie und Viszeralchirurgie entwickelt sich die interdisziplinare Viszeralmedizin. Das neue Konzept wird an einer zunehmenden Zahl von Kliniken auch organisatorisch umgesetzt und spiegelt sich in dem gemeinsamen Jahreskongress der beiden Fachgesellschaften wider. Mit der " Interdisziplinaren Viszeralmedizin" greift erstmals ein Buch diese Entwicklung auf: In kompakter, stichwortartiger Form wird das klinische Fachwissen zu den Erkrankungen und Funktionsstoerungen der Bauchorgane, den diagnostischen und therapeutischen Moeglichkeiten dargestellt. Zu allen Themen mit interdisziplinarem Bezug wurde von internistischen und chirurgischen Autoren ein gemeinsames Kapitel erarbeitet. Kontroverse Fragen der fachlichen Diskussion werden gezielt herausgegriffen und der aktuelle Stand skizziert. Die ideale Grundlage fur die interdisziplinare Arbeit auf der viszeralchirurgischen Station!

In collaboration with Consulting Editor, Dr. Norman Gitlin, Dr. Tarek Hassanein has assembled top experts in hepatology to bring current information on the topic of Hepatitis B Virus. The issue provides the most current information on the prevention and care of infected patients. Specific articles are devoted to the following topics: Global perspective on HBV infections in the era of effective vaccines; Understanding the natural history of HBV infection and the new definitions of cure and the endpoints of clinical trials; HBV/HCV coinfection in the era of HCV-DAAs; Antiretroviral effects on HBV/HIV coinfection and the natural history of liver disease; Impact of HBV infection on HCC and liver transplantation; HBV in pregnant women and their infants; WHO guidelines for prevention, care and treatment of individuals infected with HBV: A US perspective; Reconciling the difference between the major HBV treatment guidelines: AASLD, EASL, APASL; HBV/HDV coinfection: A challenge for therapeutics; and The effects of hepatic steatosis on the natural history of HBV infection. Readers will come away with the current information they need to manage patient outcomes.

Learn all you need to know about gastrointestinal drugs and their clinical use with this one-stop, rapid reference pocket guide. Brought to you by many of the world's leading GI drug experts, Pocket Guide to Gastrointestinal Drugs provides comprehensive guidance to the pharmacological properties of drugs used to treat gastrointestinal conditions, including mechanisms of action, appropriate administration, and potential adverse effects associated with their use. Organized by class of drug and ranging from PPIs to immunosupressants, each chapter first examines the specific agents within that class and then their appropriate and judicious use across a range of specific GI disorders. Key features include: * Introduction of drug class * Basic pharmacology, including mechanism of action, bioavailability, metabolism, interactions, adverse effects, toxicity, and special considerations * Dosing information for each GI condition and on- and off-label use * Consistent use of both generic and trade names throughout * Specific reference to drug use in pediatric patients and during pregnancy Perfect for quick consultation on the wards and in the office, Pocket Guide to Gastrointestinal Drugs is the ideal tool for all those managing patients with GI conditions, including gastroenterologists, GI trainees, emergency physicians, GI specialist nurses, primary care physicians and residents, intensivists and pharmacists.

In consultation with Consulting Editor, Dr. Alan Buchman, Dr. Stanley J. Naides has put together a state-of the-art issue of the Gastroenterology Clinics of North America devoted to Laboratory Monitoring of Gastrointestinal and Hepatobiliary Disease. Clinical review articles from expert authors are specifically devoted to the following: Inborn Errors of Metabolism and the GI track; Primary Immunodeficiency and the gut; Liver fibrosis determination; IBD; Autoimmune liver disease diagnosis and classification; Laboratory Diagnosis of Viral hepatitis; IgG4-RD with Emphasis on its GI Manifestation; Bowel Microbiome in Health and Disease; AAV System; and Celiac Disease. Readers will come away with the latest information they need to diagnose and monitor patients with gastrointestinal and hepatobiliary disease.

Dr. Charles Lightdale selected top expert Dr. Charles Lichtiger to serve as Guest Editor for this issue of Gastrointestinal Endoscopy Clinics devoted to Inflammatory Bowel Disease. The issue uniquely addresses the questions that arise when trying to treat and diagnose IBD. Further, it provides information on what the future might look like for endoscopists. Articles are devoted to the following topics: The Era of Anti-TNF's is Over: What do we know, don't know, and yearn to know; Prognostigating the Course of IBD- Is it an art or Science; Treat to Target: What is Target and How do we Treat; The Microbiota and the Immune Response: What is the Chicken and What is the Egg; The Role of the Radiologist in Determining Disease Severity; Capsule Endoscopy and Small Bowel Enteroscopy: Have they Rendered the Radiologist Obsolete; Dysplasia Surveillance; Endoscopic Submucosal Dissection: Are We Transitioning to it; Strictures in Crohn's Diagnosis and UC: Is there a role for the gastroenterologist, endoscopist, or is it always the surgeon; Endoscopy in the Postoperative Patient with CD or UC: Does it Translate to better Outcomes; The Role of Histology in Determining Disease Activity, Treatment, and Prognosis: Are we there yet; Perianal Disease: The role of Endoscopy, EUS, EUA, Laser Therapy, Sealing Agents, and Stem Cells; Imaging of Mucosal Inflammation: Current Developments and Future Perspectives for IBD; Surgery in IBD: Is there any need for Open Procedures. Readers will come away with a state-of-the-art understanding about the current and future clinical picture for endoscopy in IBD.

Medical Semiology Guide of the Digestive System provides a comprehensive understanding of medical semiology in the digestive system. Highly illustrated with many original images from the author's daily medical practice, the book highlights all signs of diseases and important semiological maneuvers in the field. Each chapter incorporates a specific questionnaire with important questions that should be asked to patients in different situations to obtain valuable information that helps identify rare and unusual diseases. This unique feature of the book aims to facilitate the learning process among medical students, while also acting as a quick reference guide for clinicians in practice.

Medical Semiology of the Digestive System, Part II provides a comprehensive understanding of medical semiology in the digestive system. Highly illustrated with many original images from the author's daily medical practice, the book highlights all signs of diseases and important semiological maneuvers in the field. Each chapter incorporates a specific questionnaire with important questions that should be asked to patients in different situations to obtain valuable information that helps identify rare and unusual diseases. This unique feature of the book aims to facilitate the learning process among medical students, while also acting as a quick reference guide for clinicians in practice.

In consultation with Dr. Charles Lightdale, Dr. DiMaio has assembled a list of articles devoted to endoscopy in hepatology with the most current and clinically relevant content. Dr. DiMaio invited top experts from well-known institutions to contribute reviews on the following topics: EUS in the evaluation of unexplained biliary dilation and liver function test abnormalities; EUS-guided liver biopsy; Advances in endoscopic imaging of the biliary tree; Expert evaluation of indeterminate biliary strictures; Stenting for benign and malignant biliary strictures; Endoscopic management of biliary issues in the liver transplant patient; Endoscopic management of complex biliary stone disease; EUS-guided biliary drainage; ERCP and EUS-guided drainage of the gallbladder; EUS-guided interventions for the measurement and treatment of portal hypertension; Endoscopic management of portal hypertension-related bleeding; EUS for diagnosis and staging of liver tumors; ERCP-guided ablation for cholangiocarcinoma; and EUS-guided ablation of liver tumors. Readers will come away with the most current clinical information they need to improve outcomes in patients with liver disease.

Irritable Bowel Syndrome (IBS) is the most common functional gastrointestinal disorder, causing pain, discomfort, and embarrassment to millions. While medically based treatments have demonstrated only limited effectiveness, recent research strongly supports the role of psychosocial factors in both symptom expression and symptom control. This book presents a brief cognitive-behavioral treatment approach that is suitable for use with individuals or groups. Delineating a clear medical rationale, the authors help clinicians both to reduce the stigma associated with IBS and to overcome client resistance to psychological treatment. Effective techniques are outlined for helping clients manage anxiety, anger, and shame; enhance their self-efficacy and stress management skills; and alleviate gastrointestinal distress. Session-by-session guidelines are illuminated by such useful features as sample therapist-client dialogues, lists of important points to cover, troubleshooting tips, and examples of recommended handouts and forms. Also covered in depth are treatment issues specific to women.

Esophageal Cancer and Barrett s Esophagus, 3E, focuses on these two common and key conditions that affect the esophagus, providing expert guidance to their pathogenesis, cause, prevention, diagnosis and clinical management. Top international names in the field examine each of the many issues involved, using the very latest evidence-based research, and clear, didactic advice allows the reader to understand the best methods of diagnosis and clinical management of each condition whether early or late stage. Well-illustrated and fully revised to include the latest in ACG/ASG/UEGW guidelines, it is the perfect consultation tool for gastroenterologists and oncologists managing patients with cancer of the esophagus. It is also ideal for teaching residents and fellows optimum patient management, and for identifying areas requiring future research.